Veterinary Medicines

Nobilis EDS Emulsie voor injectie

Not authorised
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis EDS Emulsie voor injectie
Nobilis EDS Emulsion injectable
Nobilis EDS Emulsion zur Injektion
Active substance:
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
Target species:
  • Chicken (pullet future breeder)
  • Chicken (pullet for egg production, future layer)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (pullet future breeder)
      • Meat and offal
        0
        day
      • Egg
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
  • Subcutaneous use
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
      • Egg
        0
        day
    • Chicken (pullet future breeder)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Nobilis EDS 500 ml PET Bottle Emulsion for injection
  • Nobilis EDS 250 ml PET Bottle Emulsion for injection
  • Nobilis EDS 500 ml glass Bottle Emulsion for injection
  • Nobilis EDS 250 ml glass Bottle Emulsion for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download